Company intelligence / Profile preview

Vail Scientific

Bloomington, Minnesota, United Statesvailscientific.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Vail Scientific has completed initial clinical trials of its non-invasive, point-of-care sepsis detection device and continues to pursue further validation and FDA clearance. The technology enables rapid identification of sepsis using proprietary nitric oxide measurement at the point of care. No published pivotal or late-stage trial results yet.

Therapeutic areas: Infectious Diseases
Modalities: Device (Non-invasive diagnostic device)
Industry: Metabolite Diagnostics

Partnerships

Minnetronix Medical

Beyond the preview

Go deeper on Vail Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vail Scientific.

Explore the full profile